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Abstract
Selective breeding of the domestic dog (Canis lupus familiaris) rigidly retains desirable features, and could inadvertently 
fix disease-causing variants within a breed. We combine phenotypic data from > 72,000 dogs with a large genotypic dataset 
to search for genes associated with cancer mortality and longevity in pedigree dog breeds. We validated previous findings 
that breeds with higher average body weight have higher cancer mortality rates and lower life expectancy. We identified a 
significant positive correlation between life span and cancer mortality residuals corrected for body weight, implying that 
long-lived breeds die more frequently from cancer compared to short-lived breeds. We replicated a number of known genetic 
associations with body weight (IGF1, GHR, CD36, SMAD2 and IGF2BP2). Subsequently, we identified five genetic variants 
in known cancer-related genes (located within SIPA1, ADCY7 and ARNT2) that could be associated with cancer mortal-
ity residuals corrected for confounding factors. One putative genetic variant was marginally significantly associated with 
longevity residuals that had been corrected for the effects of body weight; this genetic variant is located within PRDX1, a 
peroxiredoxin that belongs to an emerging class of pro-longevity associated genes. This research should be considered as an 
exploratory analysis to uncover associations between genes and longevity/cancer mortality.
Background
The World Health Organization predicts that the proportion 
of the world’s population over the age of 60 will nearly dou-
ble from 12 to 22% between 2015 and 2050 (WHO 2016). 
Ageing is the biggest risk factor for cancer (de Magalhães 
2013), which is a leading cause of deaths worldwide. For 
example, in 2018, approximately 18.1 million new cancer 
cases and 9.6 million cancer-related deaths were recorded 
globally (Bray et al. 2018). The biological complexity of 
human conditions such as cancer mortality and longevity 
has stimulated an intense search for experimental models 
that closely resemble the pathophysiological aspects of these 
processes (Kuningas et al. 2008; Alvarez 2014; de Magal-
hães 2014). As demonstrated previously for cancer and other 
traits (for example, Sutter et al. 2007; Paoloni et al. 2009; 
Pinho et al. 2012; Fenger et al. 2014; Schiffman and Breen 
2015), the identification of novel genetic variants associ-
ated with complex conditions obtained from comparative 
mammalian models such as dogs has the potential to greatly 
advance our understanding of complex human conditions.
Over the last few centuries, approximately 193 Ameri-
can Kennel Club-recognised pedigree (i.e. purebred) 
dog breeds (Canis lupus familiaris) have evolved based 
on selection for particular characteristics that have been 
fixed and maintained by selective breeding within closed 
familial lines (AKC; Club 2009; Farrell et al. 2015). Arti-
ficial selection for specific traits circumvents Darwinian 
natural selection; although desirable features are rigidly 
retained, undesirable disease-causing gene variants risk 
being inadvertently increased in frequency or even fixed in 
the gene pool. For example, selective breeding can direct 
the enrichment of disease-causing alleles which would 
reflect in the high rates of specific diseases in some breeds, 
disease-causing mutations could hitch-hike with a desir-
able phenotypic trait, or there may be a pleiotropic effect 
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of the selected variants (Sargan 2004; Karlsson and Lind-
blad-Toh 2008). In addition, the desired trait variant itself 
may lead to deleterious effects (Kanetsky et al. 2009). As 
a result of selective breeding, although a level of genetic 
heterogeneity is maintained between breeds (27% of total 
genetic variation compared to the typical 5–10% found 
in humans), some pedigree dog breeds, particularly those 
of European descent, have a reduced genetic diversity, as 
opposed to, for example, East Asian breeds (Parker et al. 
2004; Freedman et al. 2014; Wang et al. 2016). This lower 
level of genetic variation (going up to 90% loss) has been 
seen before in several breeds, when their pedigree records 
are analysed, as well as an increase in inbreeding over time 
(Leroy et al. 2006; Calboli et al. 2008; Voges and Distl 
2009; Jansson and Laikre 2014, 2018). The generation of 
pedigree dog breeds has proven to be a powerful genetic 
paradigm for the study of complex conditions such as lon-
gevity and cancer (Rowell et al. 2011; Ostrander 2012; 
Alvarez 2014; Schiffman and Breen 2015; Kaeberlein et al. 
2016; Mazzatenta et al. 2017).
Canine malignancies have been established as exceptional 
comparative models for human cancers due to their similar 
spontaneous tumour development and frequency patterns, 
shared environment, similar risk factor exposure, response to 
conventional therapies, similar underlying genetics, and the 
high level of healthcare received by both species (Fleischer 
et al. 2008; Fleming et al. 2011; Ostrander 2012; Dobson 
2013; Alvarez 2014; Ostrander et al. 2019). For example, 
using dogs as a model to study osteosarcoma has provided 
an unparalleled opportunity to understand its genetic driv-
ers and the role of metastasis in the disease, and to pilot 
new investigatory drugs that would take too long to study in 
humans (Paoloni et al. 2009; Fenger et al. 2014).
From a longevity perspective, dogs age 5–8 times faster 
than humans and generally live to old age (Rowell et al. 
2011; Kraus et al. 2013). Studies of longevity-associated 
genes in humans have generally been disappointing. With 
the exception of APOE (apolipoprotein E) (Christensen et al. 
2006), few associations between specific gene loci and lon-
gevity have been replicated in multiple human populations. 
In contrast, there have been several robust genetic findings 
in model organisms of ageing (Partridge and Gems 2007; 
Kenyon 2010). For example, Sutter et al. (2007) mapped 
body weight to a single haplotype at the IGF1 (insulin-like 
growth factor 1) locus that explained body weight varia-
tion both between and within breeds (Sutter et al. 2007); 
an observation that was repeated both in dogs (Jones et al. 
2008; Akey et al. 2010; Boyko et al. 2010; Greer et al. 2011; 
Rimbault et al. 2013) and in other model organisms (Carter 
et al. 2002). This locus in dogs has also proven to be impor-
tant in determining body weight and longevity in humans, as 
well as in other model organisms (Carter et al. 2002). These 
findings demonstrate that dogs are a suitable comparative 
genetic model, even for complex and poorly understood phe-
notypic traits such as longevity.
The aim of this experiment was to combine the recent 
availability of cancer mortality and longevity data for over 
72,000 dogs from over 70 pedigree breeds (Fleming et al. 
2011; Kraus et al. 2013) with a separate recently-published 
genotypic data set comprising over 166,171 single nucleo-
tide polymorphisms (SNPs) from over 160 pedigree breeds 
(Shannon et al. 2015) to identify novel genetic variants that 
affect cancer mortality and longevity in pedigree dog breeds. 
Further investigation of these genetic variants has the poten-
tial to reveal new genes impacting canine and human health 
and longevity.
Methods
Data sources and quality filtering
Cancer mortality rates were derived from a large data set 
of 72,376 samples from 82 North American pedigree dog 
breeds (Fleming et al. 2011). Body weight and adult life 
expectancy (life expectancy at 4 years) data were obtained 
from 74 breeds comprising 56,637 samples (Kraus et al. 
2013). Separately, a genotypic data set comprising 166,171 
SNPs from 4676 pedigree dogs from 161 breeds was 
retrieved from Shannon et al. (2015). As the number of sam-
ples per breed ranged from 4 to more than 700 for the Labra-
dor retriever (which is more than double the number of sam-
ples for the next highest breed) (Supplementary Table 1), 
we wanted to extract a roughly equal number of samples 
per breed. All samples from breeds with fewer than 30 sam-
ples were selected. For breeds with more than 30 samples 
representing the breed, 30 samples were selected at random 
to represent the breed; thus the population comprised 1274 
samples; the number of samples per breed is now in line 
with previous similar analyses (Vaysse et al. 2011; Webster 
et al. 2015). 18,748 dog genes and their chromosomal loca-
tions were obtained from the C. lupus familiaris (CanFam 
3.1) database in Ensembl BioMart version 82 (December 
2015) (Cunningham et al. 2015). Breeds that possessed both 
phenotypic and genotypic data were extracted for further 
analysis; this left a combined data set of 63 breeds (Sup-
plementary Table 1).
SNPs with a high level of missingness (> 10%), a low 
minor allele frequency (< 1%), located on sex chromo-
somes, or that were not in Hardy–Weinberg equilibrium 
among breeds (P < 0.01) were removed from the analysis 
using PLINK version 1.07 (Purcell et al. 2007). It is gener-
ally accepted that when SNPs are in strong LD, the alleles 
of some SNPs provide redundant information as the SNPs 
that they are in high LD with, as they tend to be inherited 
together. Consequently, a modest number of SNPs selected 
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from each segment would suffice to define the relevant hap-
lotypes in a population. For SNPs in high linkage disequi-
librium (r2 > 0.9), one SNP in each pair was removed. Thus, 
the quality-filtered genotypic data set comprised 96,984 
SNPs from 1274 samples from 63 pedigree dog breeds. We 
wanted to specifically focus our search on a set of candidate 
SNPs that were potentially related to longevity and cancer, 
as has previously been done many times to identify SNPs 
associated with complex traits (for example, Kulminski and 
Culminskaya 2013; Webster et al. 2015). Regarding lon-
gevity, 298 putative human ageing-related genes (https ://
genom ics.senes cence .info/genes /human .html; Supplemen-
tary Table 2a) and 1050 human homologs to model organ-
ism ageing-related genes (https ://genom ics.senes cence 
.info/genes /model s.html; Supplementary Table 2b) are col-
lectively referred to as putative longevity-associated genes 
(LAGs) and were obtained from GenAge Build 17 (Tacutu 
et al. 2013). For more information on the assignment of 
longevity-associated genes, the reader is referred to (Tacutu 
et al. 2013). Model organism genes were converted to their 
respective human homologs and after removing redundancy, 
903 LAGs remained (Supplementary Table 2c). These 903 
LAGs, combined from human and human homologs to 
model organism ageing-related genes are referred to as the 
combined set LAGs. 803 dog genes with > 70% sequence 
identity to the combined set LAGs were retrieved from 
the Ensembl BioMart database (Cunningham et al. 2015) 
(Supplementary Table 2d). The chromosomal location of 
each gene was identified using the CanFam 3.1 assembly 
in Ensembl BioMart (Supplementary Table 2e), and 2874 
of the quality-filtered SNPs located within ± 20 kb of each 
gene were identified as putatively longevity-associated and 
extracted for further analysis (Supplementary Table 2f). For 
the cancer mortality analysis, 352 genes in the dog KEGG 
pathway “cfa05200—Pathways in cancer” with Ensembl 
IDs were obtained from (Kanehisa 2000) (Supplementary 
Table 2g), and 1544 SNPs located within ± 20 kb of these 
genes were retained for further analysis (Supplementary 
Table 2h). The interval ± 20 kb was selected based on LD 
decay found in the work of Boyko et al. (2010). This value, 
while not completely conservative, it is also not found on 
the end of the LD decay curve, allowing us to detect SNPs 
in close proximity and in association with the genes here 
studied.
Spearman correlation to assess association 
between cancer mortality, body weight and life 
expectancy
Spearman’s rank correlation tests were conducted to assess 
the associations between cancer mortality rates, body weight, 
and life expectancy using SciPy version 0.16.1 (Jones et al. 
2014) in Python version 2.7.3. For the correlation analysis 
(i.e. the Results section entitled “Correlation between cancer 
mortality, body weight, and life expectancy”), there was no 
significant correlation observed between cancer mortality 
rates and life expectancy rates. To understand if the same 
effect would be observed if we considered cancer mortality 
rate residuals after correction for body weight, we conducted 
a linear regression between cancer mortality rates and body 
weight using the “linregress” function SciPy version 0.16.1.
For the association analysis between cancer mortality/
longevity-related SNPs and cancer mortality/longevity, to 
permit associations with cancer mortality rates to be inves-
tigated independently from body weight and life expectancy, 
standardised residuals for the cancer mortality rates were 
calculated after a multiple regression analysis with body 
weight and life expectancy calculated using StatsModels 
version 0.6.1 (Seabold and Perktold 2010). In addition, to 
permit association with longevity data to be investigated 
independently from body weight, standardised residuals for 
longevity were calculated after a linear regression analysis 
using SciPy version 0.16.1.
Additionally, in order to access the effect of outliers, we 
jackknifed the correlation coefficients obtained in the Spear-
man tests using the jackknife package version 2019.6 and R 
version 3.5.2.
Association analysis between SNPs of interest 
and phenotypic traits (i.e. body weight, cancer 
mortality or longevity)
PLINK version 1.07 (Purcell et al. 2007) was used to con-
duct a linear association analysis with the commonly imple-
mented additive genotypic model (Clarke et al. 2011). Three 
association analyses were conducted between (1) 96,984 
quality-filtered SNPs and body weight, (2) a set of 1544 
cancer-associated SNPs and cancer residuals (i.e. after mul-
tiple regression with body weight and life expectancy) and 
(3) a set of 2874 longevity-associated SNPs and longevity 
residuals (i.e. after linear regression with body weight). 
Corrected P values were calculated using the permutation 
procedure as described in (Vaysse et al. 2011). This proce-
dure has previously been used successfully in studies such 
as (Karlsson et al. 2007; Vaysse et al. 2011; Webster et al. 
2015) to both replicate others’ findings, and to identify novel 
genetic variants that are associated with various phenotypic 
traits. Briefly, we used a breed-specific permutation proce-
dure to determine genome-wide significance implemented 
using a Python (version 2.7.3) script. Each sample within a 
breed was assigned a phenotype corresponding to the breed-
specific value of a trait. Traits were coded as quantitative 
in these experiments (i.e. mortality residual and longevity 
residual data). An association study was performed for each 
trait followed by a permutation procedure, in which the 
phenotypes of each breed were randomised and identical 
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phenotype values were always assigned to each sample 
within the same breed. For each experiment, 1000 permu-
tations were performed. We identified the lowest P value 
(i.e. the lowest permuted P value) obtained across all of the 
SNPs in each of the 1000 permutations. Then, we calculated 
how many times our raw P value was lower than the low-
est permuted P value using the equation (1 + # times raw P 
Value was lower than the lowest permuted P values/1001). 
In this way, the raw significance value of each SNP was 
compared to the minimum permuted P value across all 
SNPs to calculate corrected significance values. SNPs that 
obtained a corrected P < 0.05 were considered significant. 
This permutation process corrects for the extreme population 
sub-structure present in dog breeds. P values are calculated 
across all of the SNPs used in each analysis. In regards to 
the correlation analysis with minor allele frequency (MAF), 
the Pearson and Spearman values were obtained using SciPy 
version 0.16.1 and the FDR was calculated using the Benja-
mini & Hochberg method.
The robustness of the identified SNPs of interest was 
tested using a resampling method for the two analyses of 
interest (i.e. cancer mortality residuals after multiple regres-
sion with body weight and life expectancy and longevity 
residuals after linear regression with body weight). The data 
were subsampled 10 times, randomly removing 10% of the 
genotypic subjects each time (samples remaining = 1147). 
As can be observed from Supplementary Tables 4b and 5b, 
the number and identities of SNPs significantly associated 
with both traits per chromosome remained relatively con-
stant across the original and resampled data sets, suggesting 
that the associations are robust and not dependent on the 
exact set of samples used in the analysis.
Results
Correlation between cancer mortality, body weight, 
and life expectancy
For 63 dog breeds (N = 1274 dogs; Supplementary Table 1), 
a data set comprising body weight, life expectancy and 
cancer mortality rates was assembled and quality filtered. 
Concordant with prior studies (Fleming et al. 2011; Dob-
son 2013), we found a strong significant positive correlation 
between cancer mortality and body weight in our dog breeds 
(R = 0.5, P = 2.88E−05, Spearman’s Test; R̂ = 0.51, Jack-
knife correlation; Fig. 1a). Additionally, in agreement with 
previous studies (Fleming et al. 2011; Kraus et al. 2013), a 
strong, significant, negative correlation between body weight 
and life expectancy was observed (R = − 0.68, P = 6.73E−10, 
Spearman’s test; R̂ = −0.69, Jackknife correlation; Fig. 1b). 
There was no significant association between the raw can-
cer mortality data and life expectancy (R = − 0.06, P = 0.63, 
Spearman’s Test; R̂ = −0.06, Jackknife correlation; Fig. 1c). 
Given the strong correlation between cancer mortality and 
body weight, and to avoid finding genetic associations with 
cancer merely due associations with body weight, a linear 
regression between body weight and cancer mortality was 
conducted to obtain cancer mortality residuals that were 
corrected for the effects of the correlation between cancer 
mortality and body weight (Fig. 1a and d). There was a mod-
erate significant positive correlation between life expectancy 
and cancer mortality residuals after linear regression with 
body weight (R = 0.24, P = 0.05, Spearman’s Test; R̂ = 0.25, 
Jackknife correlation; Fig. 1e). Overall, the bias-corrected 
jacknife estimates values ( ̂R ) were very similar to the corre-
lation coefficients, showing that outliers had little influence 
in correlations here observed.
Genetic association analysis for body weight
We performed a quantitative association analysis between all 
96,984 SNPs in the data set and body weight for 63 breeds 
with phenotypic and genotypic data (N = 1274 dogs), and 
analysed the statistical significance of each association 
using a strict permutation procedure for two reasons. First, 
there are a number of genetic variants that are well known 
to be associated with body weight both in dogs, and in other 
organisms. The replication of these observations in our 
population would serve as validation that our genetic asso-
ciation and permutation method was capable of identifying 
phenotypically relevant genetic variants. In addition, both of 
our main traits of interest, longevity and cancer mortality, 
are significantly correlated with body weight. Should any 
SNPs be found to be associated with cancer mortality or 
longevity, we aimed to understand if such associations are 
artefacts of an association with body weight. The full output 
from the association analyses between all 96,984 SNPs and 
body weight, along with the corrected P values for each 
SNP from the permutation analysis is found in Supplemen-
tary Table 3a. To check for robustness of the observations, 
the data set was resampled (Supplementary Table 3b). To 
validate our observations further, we conducted a Spearman 
correlation between per-breed body weight and per-breed 
minor allele frequency, for all 96,984 SNPs.
There were eight SNPs significantly (corrected P < 0.05) 
and a further six SNPs marginally significantly (corrected 
P < 0.1) associated with body weight from the GWAS and 
resampling analyses (Supplementary Table 3; Fig. 2); the 
majority of these SNPs are also significant in the Spear-
man correlations between MAF and trait (Supplementary 
Table 6a). From the European Variation Archive (EVA) 
(EMBL-EBI), we observed that six of the fourteen SNPs 
(rs22362978, rs22386836, rs22404565, rs9108382, 
rs22400035 and rs22422623) are within intron regions of the 
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gene insulin growth factor 1 (IGF1). One SNP (rs24163018) 
is within an intron region of growth factor receptor (GHR) 
and one SNP (rs22699215) is within an intron region of 
cluster of differentiation 36 (CD36). A further two SNPs 
(rs24445718 and rs24445907) are in close proximity 
(i.e. ± 20 kb) to the SMAD Family Member 2 (SMAD2) 
gene and one SNP (rs23867563) is within close proximity 
to the insulin-like growth factor 2 mRNA binding protein 2 
(IGF2BP2) gene (Supplementary Table 3).
Three SNPs associated with cancer mortality 
in pedigree dog breeds
To identify genetic variants that are associated with can-
cer mortality in pedigree dog breeds, we conducted a tar-
geted approach to genetic variant-trait association discov-
ery, similar to studies that have previously successfully 
identified SNPs associated with various complex traits 
(for example, Willcox et al. 2008; Kulminski and Cul-
minskaya 2013; Webster et al. 2015). A total of 352 genes 
in the dog KEGG pathway “cfa05200—Pathways in can-
cer” were retrieved from (Kanehisa 2000), and 1544 of 
the quality filtered SNPs located within ± 20 kb of these 
genes were extracted (see “Methods” section for a more 
detailed description of the SNP selection process). We per-
formed a quantitative association analysis between these 
1544 potentially cancer-related SNPs and cancer mortality 
residuals after multiple regression for body weight and life 
expectancy in the 63 breeds for which both phenotypic and 
genotypic data was available (N = 1274 dogs; see “Meth-
ods” section). The full association results for all of the 
SNPs, and the results of the resampling analysis, are found 
in Supplementary Table 4a and 4b.
Fig. 1  Correlation results for 
cancer mortality, body weight 
and life expectancy. a Raw 
cancer mortality (i.e. cancer 
mortality rate before linear 
regression with body weight) 
versus body weight (Spear-
man correlation, R = 0.5; 
P = 2.88E−05; Linear Regres-
sion, R = 0.413; P = 7.7E−04). 
b Life expectancy versus body 
weight (Spearman correlation, 
R = − 0.68; P = 6.73E−10). 
c Life expectancy versus 
raw cancer mortality (i.e. 
cancer mortality rate before 
linear regression with body 
weight) (Spearman correla-
tion, R = − 0.06; P = 0.63). d 
Cancer mortality residuals after 
linear regression with body 
weight versus body weight. e 
Life expectancy versus cancer 
mortality residuals after linear 
regression with body weight 
(Spearman correlation, R = 0.24; 
P = 0.05)
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After correction for body weight, only three SNPs 
(rs22628734, rs23539000 and rs22821286) were statistically 
significantly associated with cancer mortality residuals (cor-
rected P < 0.05); and a further two SNPs (rs23603551 and 
rs23629466) were marginally significantly associated with 
cancer mortality residuals (corrected P < 0.1) (Table 1; Sup-
plementary Table 4a, Fig. 3). Encouragingly, these five SNPs 
were consistently significant or marginally significant in the 
set of resampled data sets (Supplementary Table 4b). Three 
of the SNPs (rs23539000, rs22821286 and rs23603551) had 
uncorrected P values that were not significantly associated 
with body weight, and all of the SNPs were not significantly 
associated with body weight after permutation correction 
(Supplementary Table 6b). Only rs23539000 was in high LD 
(r2 > 0.9) with one other SNP in the original pre-quality filter 
data set comprising 166,171 SNPs obtained from (Shannon 
et al. 2015) (rs23589426, r2 = 0.91). To attempt to validate 
our observations using an independent method, we conducted 
a Spearman correlation between the per-breed MAF for all 
1544 SNPs and cancer mortality residuals. The 30 SNPs that 
obtained the lowest correlation between minor allele fre-
quency and trait is found in Supplementary Table 6c. Two of 
Fig. 2  Manhattan Plot of 
associations between SNPs 
and body weight. The points 
coloured green were sig-
nificantly associated with body 
weight after permutation and 
the points coloured blue were 
marginally significant with body 
weight after permutation. The 
points coloured black/grey (they 
are indicative of alternating 
chromosomes) are SNPs not 
associated with body weight 
after permutation
Table 1  Single nucleotide polymorphisms associated with cancer mortality residuals and longevity residuals under the additive genotypic model
Data set Chr Position (base pairs) 
according to CanFam 
3.1
SNP name (rs #) Genes that 
SNPs are 
in
Association with residu-
als; corrected P value 
(* = marginal significance)
Association with body 
weight; corrected P value
Cancer mortality residuals 2 65,016,323 rs22821286 ADCY7 0.02 1.0
3 57,088,297 rs23629466 ARNT2 0.08* 1.0
3 57,118,495 rs23539000 ARNT2 0.02 1.0
3 57,122,649 rs23603551 ARNT2 0.07* 1.0
18 51,567,888 rs22628734 SIPA1 0.002 1.0
Longevity residuals 13 50,802,666 rs9067088 – 0.08* 1.0
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the SNPs identified using the GWAS approach (rs23629466 
and rs23539000) exhibit pre-FDR P values < 0.05 from the 
Spearman correlation approach; and the strength of the cor-
relations themselves are relatively weak (R < 0.35; Supplemen-
tary Table 6b). However, given the fact that we are attempting 
to identify SNPs associated with a relatively complex trait, it 
is possible that this independent method would not identify 
our SNPs of interest as easily as for other traits, such as body 
weight as described in a previous section.
SNPs of interest were searched for in the EVA (EMBL-EBI) 
database to identify their functional consequence on protein 
structure and function. All of these SNPs are located within 
the intron regions of three genes: rs22628734 is located in 
signal-induced proliferation-associated 1 (SIPA1), rs23629466, 
rs2359000 and rs2360351 are located in aryl hydrocarbon 
receptor nuclear translocator 2 (ARNT2) and rs22821286 is 
in adenylate cyclase 7 (ADCY7) (Supplementary Table 6b).
One genetic variant on chromosomes 13 
is potentially associated with longevity residuals 
in pedigree dog breeds
Similar to the cancer mortality analysis, a targeted candidate 
gene approach was conducted to identify SNPs and genes 
associated with longevity. A data set comprising 803 genes 
that are putatively related to ageing in dogs was assembled 
(Supplementary Table 2d). 2,874 quality-filtered SNPs 
located within ± 20 kb of each potential ageing-related gene 
were identified (Supplementary Table 2f). We performed an 
association analysis between these 2,874 potentially ageing-
related SNPs and longevity residuals (i.e. after regression 
between longevity and body weight) using the same 1,274 
samples described in the previous section (see “Methods” 
section). The results from the full association analysis are 
in Supplementary Table 5a and 5b. There was one SNP of 
interest (rs9067088) that was marginally significantly associ-
ated with longevity residuals (Corrected P = 0.09; Table 1; 
Supplementary Table 5b; Fig. 4). Rs9067088 is not associ-
ated with body weight after permutation and is not in high 
linkage disequilibrium with any other SNP in the data set 
(Supplementary Table 6b). We conducted a Spearman cor-
relation between the MAF of all 2874 SNPs and longevity 
residuals. The 30 SNPs displaying the 30 lowest pre-FDR 
Spearman correlations is found in Supplementary Table 6d. 
Our SNP of interest did not demonstrate a significant cor-
relation between per-breed MAF and longevity residuals 
(Supplementary Table 6b); and is not represented in the 30 
lowest correlations between MAF and longevity residuals; 
Fig. 3  Manhattan Plot of 
association between SNPs and 
cancer mortality residuals, after 
multiple regression with life 
expectancy and body weight. 
The points coloured green were 
significantly associated with 
cancer mortality residuals after 
permutation and the points 
coloured blue were marginally 
significant with cancer mortal-
ity residuals after permutation. 
The points coloured black/grey 
(that are indicative of alternat-
ing chromosomes) are SNPs not 
associated with cancer mortality 
residuals after permutation
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however given that longevity is such a complex trait, perhaps 
a simple Spearman correlation is not sensitive enough to 
pick up such subtle genetic effects.
This SNP lies in a homolog to the human peroxiredoxin 
1 (PRDX1) gene, and is assigned to the Ensembl gene fam-
ily “PTHR10681_SF75”; a peroxiredoxin (Prx)-related gene 
family that contains PRDX1 homologs from numerous other 
species.
Discussion
Although cancer and longevity are multifactorial processes 
influenced by complex genetic and environmental factors, 
the fact that, among the pedigree dog breeds, both cancer 
incidence and lifespan vary significantly suggest that genetic 
mechanisms are involved. Furthermore, such variation can 
be detected and compared, as there is artificially enriched 
variation between pedigree breeds and relative homogeneity 
within breeds. Genetic association using breed-level clini-
cal and genetic data therefore offers a powerful approach to 
discover genetic variants underlying canine cancer and lon-
gevity with potential human applications (Sutter et al. 2007; 
Paoloni et al. 2009; Ostrander 2012; Alvarez 2014; Fenger 
et al. 2014; Schiffman and Breen 2015). We combined a 
large, recently-generated genotypic data set from over 1500 
dogs (Shannon et al. 2015) with a cancer, longevity and body 
weight data set (Fleming et al. 2011) encompassing the same 
breeds. Our aim was to locate predisposing genes across 
many breeds that affect these complex conditions, while 
using a permutation procedure that corrects for the extreme 
population sub-structure present in dog breeds. Finally, we 
considered the potential molecular mechanisms through 
which such genetic variants could exert their effect.
A number of correlations between phenotypic traits have 
previously been described in the domestic dog. For example, 
in this work we replicate the previously described negative 
correlation between body weight and lifespan and the posi-
tive correlation between body weight and cancer mortality 
rate (Fleming et al. 2011; Nunney 2013; Kraus et al. 2013; 
Song et al. 2013). The latter is in direct contrast with the 
Peto’s Paradox, which states that, because of body mass, 
large animals should be more susceptible to cancer, which 
is rare in a lot of big long-lived animals (like the elephant 
or the bowhead whale) (Tollis et al. 2017). Additionally, in 
our data set, although raw cancer mortality rate (i.e. before 
multiple regression with life expectancy and body weight) 
was surprisingly not correlated with breed lifespan, cancer 
mortality residuals after linear regression with body weight 
Fig. 4  Manhattan plot of 
association between SNPs and 
longevity residuals, after linear 
regression with body weight. 
The point coloured blue was 
marginally significant with lon-
gevity residuals after permuta-
tion. The points coloured black/
grey (that are indicative of alter-
nating chromosomes) are SNPs 
not associated with longevity 
residuals after permutation
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showed a significant positive association with lifespan, i.e. 
long-lived breeds appeared to die more frequently from can-
cer than would be expected when differences in body weight 
are controlled for. Given the strong epidemiological asso-
ciation of cancer with age (Anisimov 2003; de Magalhães 
2013), the observed relationship between life expectancy 
and cancer mortality residuals may reflect the established 
multistep model of cancer. In this scenario, alterations to 
various biological systems occur with ageing that affect can-
cer incidence and progression, independent of body weight.
We first conducted a linear genetic association study 
between all 96,984 SNPs in the data set with body weight. 
Several studies have performed multi-breed GWAS for body 
weight in dogs. In spite of variation in breeds and markers 
used in each data set, some key observations from previous 
studies are consistent with our analysis. The majority of the 
fourteen SNPs of interest that were significant or margin-
ally significant after the permutation analysis are in genes 
that are well-known for their association with body weight, 
including IGF1, GHR, CD36, SMAD2 and IGF2BP2, all of 
which have clearly been demonstrated to affect body weight 
in multiple organisms (Baker et al. 1993; Liu et al. 1993; 
Efstratiadis 1998; Sims et al. 2000; Pravenec et al. 2001; 
Carter et al. 2002; Mohan et al. 2003; Sutter et al. 2007; 
Jones et al. 2008; Chase et al. 2009; Akey et al. 2010; Boyko 
et al. 2010; Greer et al. 2011; Rimbault et al. 2013; Plassais 
et al. 2019). These results were validated using an independ-
ent approach that correlated the minor allele frequency of 
each breed with the per-breed body weight. These observa-
tions provided proof of concept that a quantitative genetic 
association analysis followed by a strict permutation proce-
dure selects phenotypically relevant genetic variants for the 
trait of interest.
We examined 1544 SNPs that potentially affect cancer 
mortality due to their proximity to known cancer-related 
genes. In total, we found five genetic variants that were sig-
nificantly associated with cancer mortality after permuta-
tion, were not significantly associated with body weight after 
permutation (and the majority were also not significantly 
associated with body weight before permutation), and were 
also observed as significant in the resampled data set. All of 
these SNPs are located within three genes: signal-induced 
proliferation-associated 1 (SIPA1), aryl hydrocarbon recep-
tor nuclear translocator 2 (ARNT2) and adenylate cyclase 7 
(ADCY7) (Supplementary Table 6); genes that have been 
repeatedly demonstrated to be associated with tumour 
growth and cancer prognoses for numerous cancer types 
(Park et al. 2005; Crawford et al. 2006; Minato and Hattori 
2009; Hsieh et al. 2009; Brooks et al. 2010; Yang et al. 2015; 
Li et al. 2015a, b; Kimura et al. 2016). It is worth noting that, 
while there exist several studies that tried to identify loci 
associated with cancer within breeds (Phillips et al. 2010; 
Shearin et al. 2012; Karyadi et al. 2013; Tonomura et al. 
2015; Melin et al. 2016; Hayward et al. 2016), there is a lack 
of studies among breeds. Two such studies found that there 
was no significant association across breeds (for osteosar-
coma and lymphoma) (Karlsson et al. 2013; Hayward et al. 
2016), and another found several loci strongly associated 
with glioma across breeds (Truvé et al. 2016).
Focusing on a set of ageing-related SNPs, we found a 
marginally significant association between one SNP and 
longevity residuals that were corrected for body weight in 
pedigree dog breeds in the original analysis, and also in the 
majority of resampled data sets. This SNP lies in a novel 
dog gene (ENSCAFG00000002337) that is a homolog to the 
human peroxiredoxin 1 (PRDX1) gene. This gene does not 
appear to be regularly discussed in relation to body weight, 
but has previously been demonstrated to be important for 
protection against apoptosis and oxidative stress, and the 
promotion of longevity in a range of organisms (Lee 2003; 
Olahova et al. 2008; Radyuk et al. 2009; Nystrom et al. 2012; 
De Haes et al. 2014). It should be noted, that this SNP was 
only marginally significant in its association with longev-
ity, and even after further permutation the significance was 
not fully reflected. Further experimental validation might 
be required in order to assess whether there is a significant 
association between this gene and longevity or if this was a 
false-positive observation.
There are a number of limitations to be considered in 
this preliminary analysis. Due to the fact some breeds used 
in this study were underrepresented, the ability to detect 
associations for these cases may be flawed. Body weight was 
an average value for each breed and not a value obtained for 
each individual sample used, which means that this study did 
not account for body weight variability between individuals 
and its impact in the detection of associations. On top of that, 
cancer mortality and life expectancy were obtained from 
previous studies that used the Veterinary Medical Database 
(VMDB) as their data source. The VMDB compiles data 
from several member hospitals in North America and it only 
represents a subsample of the whole dog population which 
can introduce some bias, specifically due to the seriousness 
of the diseases recorded, the possibility of misdiagnosis 
or misclassification of breeds, as noted by Fleming et al. 
(2011). Additionally, since the records pertain to veterinary 
practices, there is a bias towards non-healthy dogs, which 
might mean that some breed longevities were underesti-
mated. The inability to infer the exact mechanisms through 
which these genetic variants could influence longevity and 
cancer mortality is unsurprising, given the complex nature 
of both of these traits, the known difficulties of identifying 
genes associated with longevity even in much larger human 
studies and the nature of this experiment (de Magalhães 
2014). As clarified earlier, the associations described should 
be considered putative, given that the same observation was 
not made using two independent methods (possibly due to 
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the subtlety of the traits) and the fact that there is no previ-
ous literature available that identifies similar associations 
between this SNP and longevity-related traits. We stress that 
it will be essential to attempt to validate all cancer mortality 
and longevity residual findings in this research, once a suit-
able population arises. We also note that, while it is possible 
that the SNPs here identified contribute to the phenotypes 
studied, a whole genome sequence analysis would be neces-
sary to determine whether there are better casual variants 
than the variants acknowledged in this work. Experimental 
validation should also be done in an attempt to infer the 
mechanisms associated with these findings. Unfortunately, 
due to the present scarcity of high quality, large-scale dog 
SNP genotype datasets, such a replication analysis was not 
feasible at this time. In addition, it is not currently possi-
ble to assess the individual contributions of distinct cancer 
subtypes to the associations we observed between cancer 
mortality and SNPs, or the mechanism through which each 
genetic variant is exerting an effect. Indeed, it is possible that 
the SNPs found to influence cancer mortality and longev-
ity are exerting effects on multiple traits (i.e. pleiotropy), 
a scenario that is not examined in detail in this research. 
Furthermore, while this analysis was able to detect asso-
ciations between both cancer mortality and longevity with 
SNPs across all breeds, if one breed has a particular cancer 
risk SNP or longevity protective SNP that is unique to it, it’s 
very likely that such association was not properly detected 
within the confines of this study. Similarly, for breeds with 
a great predisposition to life-threatening diseases, the effects 
of longevity protective SNPs may have not been observed 
due to their untimely death.
That being said, the identification of even a single 
putative SNP that is potentially associated with longevity 
requires further attention, given the difficulty in identify-
ing SNPs associated with this trait generally. This research 
provides a starting point for additional studies to validate the 
results described herein, once such data become available.
Conclusion
Over the last two decades, the domestic dog has emerged 
as a powerful genetic paradigm for the study of heritable 
human disease due to the evolutionary history of pedi-
gree dog breeds, the high level of healthcare they typically 
receive and their genetic and pathophysiological similarities 
to humans. Using this comparative model has advanced our 
understanding of a number of human diseases and poten-
tial therapies, such as disorders associated with immuno-
deficiency, cancer, and metabolic disease. In particular, 
furthering our understanding of the molecular mechanisms 
responsible for cancer and longevity in dogs will aid drug 
development in the comparable human conditions. This 
investigation identified genetic variants associated with 
cancer mortality and longevity. Although we were able to 
replicate some previous findings for genetic associations 
between SNPs and body weight, and also validate these 
findings using two independent methods, the same cannot 
be said for the putative genetic associations that were iden-
tified between SNPs and cancer mortality/longevity. Thus, 
we stress that this analysis should be considered exploratory 
and the results considered as indicative, and we suggest that 
further studies are warranted to confirm these associations 
and further explore the relationships of the identified genes 
with cancer and longevity in dogs and humans.
Acknowledgements The authors wish to thank past and present mem-
bers of the Integrative Genomics of Ageing Group for useful sugges-
tions and discussions, in particular Shona Wood, André Macedo, 
and Ricardo Miragaia.
Author contributions JPM, CTF, and AD conceived the study. AD 
performed analysis. AD and IL prepared figures. AD, IL, GM, CTF, 
and PG drafted and finalised the paper. All authors read and approved 
the final manuscript.
Funding AD was supported by a Wellcome Trust Grant 
(104978/Z/14/Z) to JPM and a European Molecular Biology Organi-
zation (EMBO) fellowship. IL is supported by a BBSRC Grant (BB/
R014949/1) to JPM. This research was also funded by a studentship 
from the University of Liverpool to GM. The funders had no role in 
study design, data collection and analysis, decision to publish, or prepa-
ration of the manuscript.
Availability of data and materials All data resulting from this work is 
available publicly in the Supplementary Material at Github (https ://
githu b.com/magla b/dog-suppl ement ary). All of the SNP data is avail-
able publicly from https ://datad ryad.org/resou rce/doi:10.5061/dryad 
.v9t5h .
Compliance with ethical standards 
Conflict of interest The authors declare that they have no competing 
interests.
Ethical approval No animal samples were collected during this study 
and no novel data was generated by us, all data was previously avail-
able; and no permission was needed to use the data.
Consent for publication Not applicable.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
A scan for genes associated with cancer mortality and longevity in pedigree dog breeds 
1 3
References
AKC Dog Breeds (2020) https ://www.akc.org/dog-breed s/. Accessed 
15 Jun 2020
Akey JM, Ruhe AL, Akey DT et al (2010) Tracking footprints of 
artificial selection in the dog genome. Proc Natl Acad Sci USA 
107:1160–1165. https ://doi.org/10.1073/pnas.09099 18107 
Alvarez CE (2014) Naturally occurring cancers in dogs: insights for 
translational genetics and medicine. ILAR J 55:16–45. https ://
doi.org/10.1093/ilar/ilu01 0
Anisimov VN (2003) The relationship between aging and carcinogen-
esis: a critical appraisal. Crit Rev Oncol Hematol 45:277–304. 
https ://doi.org/10.1016/S1040 -8428(02)00121 -X
Baker J, Liu J-P, Robertson EJ, Efstratiadis A (1993) Role of insu-
lin-like growth factors in embryonic and postnatal growth. Cell 
75:73–82. https ://doi.org/10.1016/S0092 -8674(05)80085 -6
Boyko AR, Quignon P, Li L et al (2010) A simple genetic architecture 
underlies morphological variation in dogs. PLoS Biol 8:e1000451. 
https ://doi.org/10.1371/journ al.pbio.10004 51
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statis-
tics 2018: GLOBOCAN estimates of incidence and mortality 
worldwide for 36 cancers in 185 countries. CA Cancer J Clin 
68:394–424. https ://doi.org/10.3322/caac.21492 
Brooks R, Kizer N, Nguyen L et al (2010) Polymorphisms in MMP9 
and SIPA1 are associated with increased risk of nodal metastases 
in early-stage cervical cancer. Gynecol Oncol 116:539–543. https 
://doi.org/10.1016/j.ygyno .2009.09.037
Calboli FCF, Sampson J, Fretwell N, Balding DJ (2008) Population 
structure and inbreeding from pedigree analysis of purebred 
dogs. Genetics 179:593–601. https ://doi.org/10.1534/genet 
ics.107.08495 4
Carter CS, Ramsey MM, Sonntag WE (2002) A critical analysis of the 
role of growth hormone and IGF-1 in aging and lifespan. Trends 
Genet 18:295–301. https ://doi.org/10.1016/S0168 -9525(02)02696 
-3
Chase K, Jones P, Martin A et al (2009) Genetic mapping of fixed 
phenotypes: disease frequency as a breed characteristic. J Hered 
100:S37–S41. https ://doi.org/10.1093/jhere d/esp01 1
Christensen K, Johnson TE, Vaupel JW (2006) The quest for genetic 
determinants of human longevity: challenges and insights. Nat 
Rev Genet 7:436–448. https ://doi.org/10.1038/nrg18 71
Clarke GM, Anderson CA, Pettersson FH et al (2011) Basic statistical 
analysis in genetic case–control studies. Nat Protoc 6:121–133. 
https ://doi.org/10.1038/nprot .2010.182
Club K (2009) The Kennel Club’s illustrated breed standards: the offi-
cial guide to registered breeds
Crawford NP, Ziogas A, Peel DJ et al (2006) Germline polymorphisms 
in SIPA1 are associated with metastasis and other indicators of 
poor prognosis in breast cancer. Breast Cancer Res 8:R16. https 
://doi.org/10.1186/bcr13 89
Cunningham F, Amode MR, Barrell D et al (2015) Ensembl 2015. 
Nucleic Acids Res 43:D662–D669. https ://doi.org/10.1093/nar/
gku10 10
De Haes W, Frooninckx L, Van Assche R et al (2014) Metformin 
promotes lifespan through mitohormesis via the peroxiredoxin 
PRDX-2. Proc Natl Acad Sci USA 111:E2501–E2509. https ://doi.
org/10.1073/pnas.13217 76111 
de Magalhães JP (2013) How ageing processes influence cancer. Nat 
Rev Cancer 13:357–365. https ://doi.org/10.1038/nrc34 97
de Magalhães JP (2014) Why genes extending lifespan in model organ-
isms have not been consistently associated with human longevity 
and what it means to translation research. Cell Cycle 13:2671–
2673. https ://doi.org/10.4161/15384 101.2014.95015 1
Dobson JM (2013) Breed-predispositions to cancer in pedigree dogs. 
ISRN Vet Sci 2013:1–23. https ://doi.org/10.1155/2013/94127 5
Efstratiadis A (1998) Genetics of mouse growth. Int J Dev Biol 
42:955–976
EMBL-EBI European Variation Archivev(2019) https ://www.ebi.ac.uk/
eva/. Accessed 25 Apr 2019
Farrell LL, Schoenebeck JJ, Wiener P et al (2015) The challenges 
of pedigree dog health: approaches to combating inherited dis-
ease. Canine Genet Epidemiol 2:3. https ://doi.org/10.1186/s4057 
5-015-0014-9
Fenger JM, London CA, Kisseberth WC (2014) Canine osteosarcoma: 
a naturally occurring disease to inform pediatric oncology. ILAR 
J 55:69–85. https ://doi.org/10.1093/ilar/ilu00 9
Fleischer S, Sharkey M, Mealey K et al (2008) Pharmacogenetic 
and metabolic differences between dog breeds: their impact on 
canine medicine and the use of the dog as a preclinical animal 
model. AAPS J 10:110–119. https ://doi.org/10.1208/s1224 
8-008-9011-1
Fleming JM, Creevy KE, Promislow DEL (2011) Mortality in North 
American dogs from 1984 to 2004: an investigation into age-, 
size-, and breed-related causes of death. J Vet Intern Med 25:187–
198. https ://doi.org/10.1111/j.1939-1676.2011.0695.x
Freedman AH, Gronau I, Schweizer RM et al (2014) Genome sequenc-
ing highlights the dynamic early history of dogs. PLoS Genet 
10:e1004016. https ://doi.org/10.1371/journ al.pgen.10040 16
Greer KA, Hughes LM, Masternak MM (2011) Connecting serum 
IGF-1, body size, and age in the domestic dog. Age (Omaha) 
33:475–483. https ://doi.org/10.1007/s1135 7-010-9182-4
Hayward JJ, Castelhano MG, Oliveira KC et al (2016) Complex dis-
ease and phenotype mapping in the domestic dog. Nat Commun 
7:10460. https ://doi.org/10.1038/ncomm s1046 0
Hsieh S-M, Smith RA, Lintell NA et al (2009) Polymorphisms of the 
SIPA1 gene and sporadic breast cancer susceptibility. BMC Can-
cer 9:331. https ://doi.org/10.1186/1471-2407-9-331
Jansson M, Laikre L (2014) Recent breeding history of dog breeds 
in Sweden: modest rates of inbreeding, extensive loss of genetic 
diversity and lack of correlation between inbreeding and health. 
J Anim Breed Genet 131:153–162. https ://doi.org/10.1111/
jbg.12060 
Jansson M, Laikre L (2018) Pedigree data indicate rapid inbreeding and 
loss of genetic diversity within populations of native, traditional 
dog breeds of conservation concern. PLoS ONE 13:e0202849. 
https ://doi.org/10.1371/journ al.pone.02028 49
Jones P, Chase K, Martin A et al (2008) Single-nucleotide-polymor-
phism-based association mapping of dog stereotypes. Genetics 
179:1033–1044. https ://doi.org/10.1534/genet ics.108.08786 6
Jones E, Oliphant T, Peterson P (2014) {SciPy}: open source scientific 
tools for {Python}
Kaeberlein M, Creevy KE, Promislow DEL (2016) The dog aging 
project: translational geroscience in companion animals. Mamm 
Genome 27:279–288. https ://doi.org/10.1007/s0033 5-016-9638-7
Kanehisa M (2000) KEGG: Kyoto Encyclopedia of Genes and 
Genomes. Nucleic Acids Res 28:27–30. https ://doi.org/10.1093/
nar/28.1.27
Kanetsky PA, Mitra N, Vardhanabhuti S et al (2009) Common variation 
in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. 
Nat Genet 41:811–815. https ://doi.org/10.1038/ng.393
Karlsson EK, Lindblad-Toh K (2008) Leader of the pack: gene map-
ping in dogs and other model organisms. Nat Rev Genet 9:713–
725. https ://doi.org/10.1038/nrg23 82
Karlsson EK, Baranowska I, Wade CM et al (2007) Efficient mapping 
of Mendelian traits in dogs through genome-wide association. Nat 
Genet 39:1321–1328. https ://doi.org/10.1038/ng.2007.10
Karlsson EK, Sigurdsson S, Ivansson E et al (2013) Genome-wide 
analyses implicate 33 loci in heritable dog osteosarcoma, includ-
ing regulatory variants near CDKN2A/B. Genome Biol 14:R132. 
https ://doi.org/10.1186/gb-2013-14-12-r132
 A. Doherty et al.
1 3
Karyadi DM, Karlins E, Decker B et al (2013) A copy number vari-
ant at the KITLG locus likely confers risk for canine squamous 
cell carcinoma of the digit. PLoS Genet 9:e1003409. https ://doi.
org/10.1371/journ al.pgen.10034 09
Kenyon CJ (2010) The genetics of ageing. Nature 464:504–512. https 
://doi.org/10.1038/natur e0898 0
Kimura Y, Kasamatsu A, Nakashima D et al (2016) ARNT2 regu-
lates tumoral growth in oral squamous cell carcinoma. J Cancer 
7:702–710. https ://doi.org/10.7150/jca.14208 
Kraus C, Pavard S, Promislow DEL (2013) The size-life span trade-off 
decomposed: why large dogs die young. Am Nat 181:492–505. 
https ://doi.org/10.1086/66966 5
Kulminski AM, Culminskaya I (2013) Genomics of human health 
and aging. Age (Omaha) 35:455–469. https ://doi.org/10.1007/
s1135 7-011-9362-x
Kuningas M, Mooijaart SP, van Heemst D et al (2008) Genes encod-
ing longevity: from model organisms to humans. Aging Cell 
7:270–280. https ://doi.org/10.1111/j.1474-9726.2008.00366 .x
Lee T-H (2003) Peroxiredoxin II is essential for sustaining life span 
of erythrocytes in mice. Blood 101:5033–5038. https ://doi.
org/10.1182/blood -2002-08-2548
Leroy G, Rognon X, Varlet A et al (2006) Genetic variability in 
French dog breeds assessed by pedigree data. J Anim Breed 
Genet 123:1–9. https ://doi.org/10.1111/j.1439-0388.2006.00565 
.x
Li C, Xie J, Lu Z et al (2015a) ADCY7 supports development of acute 
myeloid leukemia. Biochem Biophys Res Commun 465:47–52. 
https ://doi.org/10.1016/j.bbrc.2015.07.123
Li W, Liang Y, Yang B et al (2015b) Downregulation of ARNT2 pro-
motes tumor growth and predicts poor prognosis in human hepa-
tocellular carcinoma. J Gastroenterol Hepatol 30:1085–1093. https 
://doi.org/10.1111/jgh.12905 
Liu JP, Baker J, Perkins AS et al (1993) Mice carrying null mutations 
of the genes encoding insulin-like growth factor I (Igf-1) and type 
1 IGF receptor (Igf1r). Cell 75:59–72
Mazzatenta A, Carluccio A, Robbe D et al (2017) The companion dog 
as a unique translational model for aging. Semin Cell Dev Biol 
70:141–153. https ://doi.org/10.1016/j.semcd b.2017.08.024
Melin M, Rivera P, Arendt M et al (2016) Genome-wide analysis 
identifies germ-line risk factors associated with canine mammary 
tumours. PLOS Genet 12:e1006029. https ://doi.org/10.1371/journ 
al.pgen.10060 29
Minato N, Hattori M (2009) Spa-1 (Sipa1) and Rap signaling in leu-
kemia and cancer metastasis. Cancer Sci 100:17–23. https ://doi.
org/10.1111/j.1349-7006.2008.01011 .x
Mohan S, Richman C, Guo R et al (2003) Insulin-Like growth factor 
regulates peak bone mineral density in mice by both growth hor-
mone-dependent and -independent mechanisms. Endocrinology 
144:929–936. https ://doi.org/10.1210/en.2002-22094 8
Nunney L (2013) The real war on cancer: the evolutionary dynamics of 
cancer suppression. Evol Appl 6:11–19. https ://doi.org/10.1111/
eva.12018 
Nystrom T, Yang J, Molin M (2012) Peroxiredoxins, gerontogenes link-
ing aging to genome instability and cancer. Genes Dev 26:2001–
2008. https ://doi.org/10.1101/gad.20000 6.112
Olahova M, Taylor SR, Khazaipoul S et al (2008) A redox-sensitive 
peroxiredoxin that is important for longevity has tissue- and 
stress-specific roles in stress resistance. Proc Natl Acad Sci USA 
105:19839–19844. https ://doi.org/10.1073/pnas.08055 07105 
Ostrander EA (2012) Both ends of the leash—the human links to good 
dogs with bad genes. N Engl J Med 367:636–646. https ://doi.
org/10.1056/NEJMr a1204 453
Ostrander EA, Dreger DL, Evans JM (2019) Canine cancer genom-
ics: lessons for canine and human health. Annu Rev Anim Biosci 
7:449–472. https ://doi.org/10.1146/annur ev-anima l-03011 
7-01452 3
Paoloni M, Davis S, Lana S et  al (2009) Canine tumor cross-
species genomics uncovers targets linked to osteosar-
coma progression. BMC Genomics 10:625. https ://doi.
org/10.1186/1471-2164-10-625
Park Y-G, Zhao X, Lesueur F et al (2005) Sipa1 is a candidate for 
underlying the metastasis efficiency modifier locus Mtes1. Nat 
Genet 37:1055–1062. https ://doi.org/10.1038/ng163 5
Parker HG, Kim LV, Sutter NB et al (2004) Genetic structure of the 
purebred domestic dog. Science 304:1160–1164. https ://doi.
org/10.1126/scien ce.10974 06
Partridge L, Gems D (2007) Benchmarks for ageing studies. Nature 
450:165–167. https ://doi.org/10.1038/45016 5a
Phillips JC, Lembcke L, Chamberlin T (2010) A novel locus for canine 
osteosarcoma (OSA1) maps to CFA34, the canine orthologue of 
human 3q26. Genomics 96:220–227. https ://doi.org/10.1016/j.
ygeno .2010.07.002
Pinho SS, Carvalho S, Cabral J et al (2012) Canine tumors: a spontane-
ous animal model of human carcinogenesis. Transl Res 159:165–
172. https ://doi.org/10.1016/j.trsl.2011.11.005
Plassais J, Kim J, Davis BW et al (2019) Whole genome sequenc-
ing of canids reveals genomic regions under selection and vari-
ants influencing morphology. Nat Commun 10:1489. https ://doi.
org/10.1038/s4146 7-019-09373 -w
Pravenec M, Landa V, Zidek V et al (2001) Transgenic rescue of defec-
tive Cd36 ameliorates insulin resistance in spontaneously hyper-
tensive rats. Nat Genet 27:156–158. https ://doi.org/10.1038/84777 
Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for 
whole-genome association and population-based linkage analyses. 
Am J Hum Genet 81:559–575. https ://doi.org/10.1086/51979 5
Radyuk SN, Michalak K, Klichko VI et al (2009) Peroxiredoxin 5 
confers protection against oxidative stress and apoptosis and also 
promotes longevity in Drosophila. Biochem J 419:437–445. https 
://doi.org/10.1042/BJ200 82003 
Rimbault M, Beale HC, Schoenebeck JJ et al (2013) Derived variants 
at six genes explain nearly half of size reduction in dog breeds. 
Genome Res 23:1985–1995. https ://doi.org/10.1101/gr.15733 
9.113
Rowell JL, McCarthy DO, Alvarez CE (2011) Dog models of natu-
rally occurring cancer. Trends Mol Med 17:380–388. https ://doi.
org/10.1016/j.molme d.2011.02.004
Sargan DR (2004) IDID: inherited diseases in dogs: web-based infor-
mation for canine inherited disease genetics. Mamm Genome 
15:503–506. https ://doi.org/10.1007/s0033 5-004-3047-z
Schiffman JD, Breen M (2015) Comparative oncology: what dogs 
and other species can teach us about humans with cancer. Philos 
Trans R Soc B Biol Sci 370:20140231. https ://doi.org/10.1098/
rstb.2014.0231
Seabold S, Perktold J (2010) Statsmodels: econometric and statistical 
modeling with python. In: Proceedings of the 9th python in sci-
ence conference
Shannon LM, Boyko RH, Castelhano M et al (2015) Genetic structure 
in village dogs reveals a Central Asian domestication origin. Proc 
Natl Acad Sci USA 112:13639–13644. https ://doi.org/10.1073/
pnas.15162 15112 
Shearin AL, Hedan B, Cadieu E et al (2012) The MTAP-CDKN2A 
locus confers susceptibility to a naturally occurring canine cancer. 
Cancer Epidemiol Biomarkers Prev 21:1019–1027. https ://doi.
org/10.1158/1055-9965.EPI-12-0190-T
Sims NA, Clément-Lacroix P, Da Ponte F et al (2000) Bone homeo-
stasis in growth hormone receptor–null mice is restored by IGF-I 
but independent of Stat5. J Clin Invest 106:1095–1103. https ://
doi.org/10.1172/JCI10 753
Song RB, Vite CH, Bradley CW, Cross JR (2013) Postmortem evalua-
tion of 435 cases of intracranial neoplasia in dogs and relationship 
of neoplasm with breed, age, and body weight. J Vet Intern Med 
27:1143–1152. https ://doi.org/10.1111/jvim.12136 
A scan for genes associated with cancer mortality and longevity in pedigree dog breeds 
1 3
Sutter NB, Bustamante CD, Chase K et al (2007) A single IGF1 allele 
is a major determinant of small size in dogs. Science 316:112–
115. https ://doi.org/10.1126/scien ce.11370 45
Tacutu R, Craig T, Budovsky A et al (2013) Human ageing genomic 
resources: integrated databases and tools for the biology and 
genetics of ageing. Nucleic Acids Res 41:D1027–D1033. https ://
doi.org/10.1093/nar/gks11 55
Tollis M, Boddy AM, Maley CC (2017) Peto’s paradox: how has evolu-
tion solved the problem of cancer prevention? BMC Biol 15:60. 
https ://doi.org/10.1186/s1291 5-017-0401-7
Tonomura N, Elvers I, Thomas R et al (2015) Genome-wide associa-
tion study identifies shared risk loci common to two malignan-
cies in golden retrievers. PLOS Genet 11:e1004922. https ://doi.
org/10.1371/journ al.pgen.10049 22
Truvé K, Dickinson P, Xiong A et al (2016) Utilizing the Dog genome 
in the search for novel candidate genes involved in glioma devel-
opment—genome wide association mapping followed by tar-
geted massive parallel sequencing identifies a strongly associated 
locus. PLOS Genet 12:e1006000. https ://doi.org/10.1371/journ 
al.pgen.10060 00
Vaysse A, Ratnakumar A, Derrien T et al (2011) Identification of 
genomic regions associated with phenotypic variation between 
dog breeds using selection mapping. PLoS Genet 7:e1002316. 
https ://doi.org/10.1371/journ al.pgen.10023 16
Voges S, Distl O (2009) Inbreeding trends and pedigree analysis of 
Bavarian mountain hounds, Hanoverian hounds and Tyrolean 
hounds. J Anim Breed Genet 126:357–365. https ://doi.org/10.1
111/j.1439-0388.2009.00800 .x
Wang G-D, Zhai W, Yang H-C et al (2016) Out of southern East Asia: 
the natural history of domestic dogs across the world. Cell Res 
26:21–33. https ://doi.org/10.1038/cr.2015.147
Webster MT, Kamgari N, Perloski M et al (2015) Linked genetic 
variants on chromosome 10 control ear morphology and body 
mass among dog breeds. BMC Genomics 16:474. https ://doi.
org/10.1186/s1286 4-015-1702-2
WHO (2016) Ageing and Health. https ://www.who.int/en/news-room/
fact-sheet s/detai l/agein g-and-healt h. Accessed 3 Dec 2019
Willcox BJ, Donlon TA, He Q et al (2008) FOXO3A genotype is 
strongly associated with human longevity. Proc Natl Acad Sci 
USA 105:13987–13992. https ://doi.org/10.1073/pnas.08010 30105 
Yang B, Yang E, Liao H et al (2015) ARNT2 is downregulated and 
serves as a potential tumor suppressor gene in non-small cell lung 
cancer. Tumor Biol 36:2111–2119. https ://doi.org/10.1007/s1327 
7-014-2820-1
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
